Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Portugal
Clinical trial register · Portugal

Clinical Trials in Portugal

Every study on the ClinicalTrials.gov registry that lists a site in Portugal and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1109 matching records held by the registry are in this view. Synced 17 Nov 2026, 03:21 UTC
1109
Studies in scope
all four open statuses
530
Recruiting now
open to new participants
282
Lead sponsors
across recruiting studies
Top sites
Lisbon 17 Porto 13 Matosinhos Municipality 7 Vila Nova de Gaia 6 Ponte de Lima 4
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Janssen Research & Development, LLC39 Novartis Pharmaceuticals36 Universidade do Porto35 AbbVie33 Hoffmann-La Roche33 AstraZeneca33 Merck Sharp & Dohme LLC30 University of Coimbra21 Novo Nordisk A/S21 Amgen19 Boehringer Ingelheim19 Sanofi18 Bristol-Myers Squibb17 Egas Moniz - Cooperativa de Ensino Superior, CRL16 Bayer14 Eli Lilly and Company13 Daiichi Sankyo13 Aveiro University12 argenx10 University of Minho9 GlaxoSmithKline9 Universidade Nova de Lisboa8 European Organisation for Research and Treatment of Cancer - EORTC8 Alnylam Pharmaceuticals7 Fundacao Champalimaud7 University of Lisbon7 Medtronic7 Association for Innovation and Biomedical Research on Light and Image7 Takeda7 Abbott Medical Devices6 Genmab6 Bioceramed5 Ionis Pharmaceuticals, Inc.5 University Institute of Maia5 Mirati Therapeutics Inc.5 Faculdade de Motricidade Humana5 Lusofona University5 University of Beira Interior5 Instituto Politécnico de Leiria5 Polytechnic Institute of Porto5 Celgene5 Escola Superior de Tecnologia da Saúde do Porto5 Clinical Academic Center (2CA-Braga)4 Centro Hospitalar de Lisboa Central4 Alexion Pharmaceuticals, Inc.4 Pfizer4 Biotronik SE & Co. KG4 Instituto Valenciano de Infertilidade de Lisboa4 University College, London4 Biogen4 ViiV Healthcare4 Unidade Local de Saúde de Coimbra, EPE4 Ipsen4 ISPA - Instituto Universitario de Ciencias Psicologicas, Sociais e da Vida4 Ultragenyx Pharmaceutical Inc4 University of Maia4 MicroPort CRM4 Gilead Sciences4 Lisbon Academic Medical Center - Centro Académico de Medicina de Lisboa4 University of Trás-os-Montes and Alto Douro3 Azafaros B.V.3 Longboard Pharmaceuticals3 University Hospital, Basel, Switzerland3 Xenon Pharmaceuticals Inc.3 Seagen, a wholly owned subsidiary of Pfizer3 Vertex Pharmaceuticals Incorporated3 Viatris Innovation GmbH3 Unidade Local de Saúde do Alto Ave, EPE3 Gulbenkian Institute for Molecular Medicine3 Fundación EPIC3 European Myeloma Network B.V.3 QED Therapeutics, a BridgeBio company3 GLSMED Learning Health S.A.3 Grupo Lusófona3 Boston Scientific Corporation3 Inmunotek S.L.3 International Extranodal Lymphoma Study Group (IELSG)3 Insel Gruppe AG, University Hospital Bern3 University of Évora3 Implantology Institute3 H. Lundbeck A/S3 Genzyme, a Sanofi Company3 Centro Hospitalar De São João, E.P.E.2 Leiden University Medical Center2 Biohaven Therapeutics Ltd.2 Actelion2 Atlantica - Instituto Universitario2 Jazz Pharmaceuticals2 Kartos Therapeutics, Inc.2 Exelixis2 Chugai Pharmaceutical2 Instituto Politécnico de Bragança2 Instituto de Saude Publica da Universidade do Porto2 MedSIR2 The Lymphoma Academic Research Organisation2 Hospital Central do Funchal2 Universidade da Coruña2 Celldex Therapeutics2 Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 Harokopio University2 Xeltis2 Weill Medical College of Cornell University2 Medtronic Cardiovascular2 University of Milano Bicocca2 Region Skane2 Hospital do Divino Espírito Santo de Ponta Delgada2 Universitaire Ziekenhuizen KU Leuven2 Alliance Foundation Trials, LLC.2 Otsuka Pharmaceutical Development & Commercialization, Inc.2 Charite University, Berlin, Germany2 Instituto Politécnico de Setúbal2 Unidade Local de Saúde São João, Oporto2 Portuguese Oncology Institute, Coimbra2 mAbxience Research S.L.2 Loxo Oncology, Inc.2 UMC Utrecht2 Portuguese Association of Interventional Cardiology2 Eidos Therapeutics, a BridgeBio company2 Astellas Pharma Global Development, Inc.2 Olema Oncology, Inc.2 Incyte Corporation2 Maria Paço2 IRCCS San Raffaele2 Stemline Therapeutics, Inc.2 MoonLake Immunotherapeutics AG2 BeOne Medicines2 EyeBiotech Ltd.2 Cooperativa de Ensino Superior, Politécnico e Universitário2 Janssen Pharmaceutica N.V., Belgium2 Cytokinetics2 ADVANCED MARKER DISCOVERY S.L.2 PharmaMar2 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company2 Leica Microsystems (Schweiz) AG2 Travere Therapeutics, Inc.2 Polytechnic University of Santarém2 Glycomine, Inc.2 Eikon Therapeutics2 Euresist Network GEIE2 Jules Bordet Institute1 Universidade do Algarve1 Hospital Garcia de Orta1 Hydrumedical1 Biosense Webster, Inc.1 Janssen Scientific Affairs, LLC1 Meril Life Sciences Pvt. Ltd.1 Zogenix, Inc.1 Sir Mortimer B. Davis - Jewish General Hospital1 Hugo César Vicente1 Technical University of Lisbon1 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico1 ETOP IBCSG Partners Foundation1 Cyprus Institute of Neurology and Genetics1 Lacer S.A.1 Genentech, Inc.1 Local Health Unit Barcelos/Esposende, Public Health Unit1 Grifols Therapeutics LLC1 NeuroDerm Ltd.1 Noucor Health S.A.1 University of Michigan1 University of Mons1 Tampere University1 Summit Therapeutics1 Fondazione Don Carlo Gnocchi ETS1 SymBio Pharmaceuticals1 Philips Clinical & Medical Affairs Global1 University of Oxford1 Academisch Ziekenhuis Maastricht1 Copenhagen University Hospital, Rigshospitalet1 Celcuity Inc1 Occlutech International AB1 BioProtect1 Oncorena AB1 Eske Kvanner Aasvang1 Manuel Monreal1 ONL Therapeutics1 Philipp Dutkowski1 Sonia Batista1 Portucalense University1 Inventiva Pharma1 University Fernando Pessoa1 Rita Alexandra Afonso da Costa1 Amicus Therapeutics1 Mats Heyman1 Merit Medical Systems, Inc.1 Universidade Católica Portuguesa1 Pharming Technologies B.V.1 OHB Neonatology Ltd.1 General Practitioners Research Institute1 Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea1 Deciphera Pharmaceuticals, LLC1 Medical University of South Carolina1 OptymEdge, LLC1 Instituto Portugues de Oncologia, Francisco Gentil, Porto1 TransThera Sciences (Nanjing), Inc.1 Julius Clinical1 Astria Therapeutics, Inc.1 Pedro Morgado1 Assistance Publique - Hôpitaux de Paris1 Masaryk University1 Inhibikase Therapeutics1 L'Oreal1 Physio-Assist1 Colorado Prevention Center1 Sociedade Portuguesa de Reumatologia1 Pierre Fabre Medicament1 AIRNA Corporation1 Acerta Pharma BV1 ProbiSearch SL1 Escola Superior de Saúde - Universidade do Algarve1 McMaster University1 Hospital de Braga1 Eduarda Oliosi, MS1 University Medical Center Groningen1 SOLTI Breast Cancer Research Group1 Hospital de Sao Sebastiao1 Instituto de Investigación Biomédica de Salamanca1 Immunovant Sciences GmbH1 Associação para o Desenvolvimento do Centro Académico de Investigação e Formação Biomédica do Algarv1 Agios Pharmaceuticals, Inc.1 Limacorporate S.p.a1 Medtronic Cardiac Ablation Solutions1 Albino Maia1 Repertoire Immune Medicines1 National Institute of Oncology, Hungary1 Biocodex1 UCB Biopharma SRL1 PedNet Haemophilia Research Foundation1 MapLight Therapeutics1 Artur Salgado SA1 CUTISS AG1 Janssen-Cilag Farmaceutica Ltda.1 German Heart Institute1 Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 Prilenia1 United Therapeutics1 Wissenschaftliches Institut Bethanien e.V1 Escola Superior de Saúde Norte da Cruz Vermelha Portuguesa1 Centro Hospitalar Universitario do Algarve1 Kura Oncology, Inc.1 Teknimed1 Generate Biomedicines1 University Hospital, Gasthuisberg1 Vedanta Biosciences, Inc.1 Memorial Sloan Kettering Cancer Center1 Sunnybrook Health Sciences Centre1 Xencor, Inc.1 Kedrion S.p.A.1 Vir Biotechnology, Inc.1 CSL Behring1 Anthogyr1 Immunocore Ltd1 Ascendis Pharma A/S1 Essilor International1 Medical University of Graz1 Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS1 Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD1 Ottimo Pharma Limited1 Tectonic Therapeutic1 Lexicon Pharmaceuticals1 Advanced Accelerator Applications1 Syndax Pharmaceuticals1 Shanghai MicroPort CardioFlow Medtech Co., Ltd.1 Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1 Associazione Italiana Ematologia Oncologia Pediatrica1 Firalis SA1 Terremoto Biosciences Inc.1 Actuate Therapeutics Inc.1 Nimbus Wadjet, Inc.1 EP Solutions SA1 Indiana University1 Cintia Silva Fassarella1 Instituto Portugues Oncologia de Lisboa Francisco Gentil1 Contineum Therapeutics1 Z Optics, Inc.1 P+F Products + Features GmbH1 Intellia Therapeutics1 X4 Pharmaceuticals1 CytoSorbents, Inc1 Nobel Biocare1 Clinical Hospital Colentina1 Relay Therapeutics, Inc.1 Geron Corporation1 Indizen Optical Technologies, S.L.U.1 Princess Maxima Center for Pediatric Oncology1 Calico Life Sciences LLC1 OSE Immunotherapeutics1 Newcastle University1 José Gabriel da Silva Figueiredo1 BioNTech SE1 University of Salamanca1 PedAL BCU, LLC1 Enrique Rodilla1 Unidade Local de Saúde Santa Maria1 Valvular Heart Disease in Women Registry1 Ascendis Pharma Growth Disorders A/S1 GT Metabolic Solutions, Inc.1 Policlinic Hospital "G. Rodolico"1 University Hospital, Toulouse1 Insmed Incorporated1 Henrique Sousa1 Imbria Pharmaceuticals, Inc.1 SK Life Science, Inc.1 Unidade Local de Saude Sao Jose1 Xoft, Inc.1 Hospital de Santa Cruz, Portugal1 Bicara Therapeutics1 University Rovira i Virgili1 Fundación Española de Hematología y Hemoterapía1 Fundació d'investigació Sanitària de les Illes Balears1 Abivax S.A.1 Johnson & Johnson Enterprise Innovation Inc.1 Artiva Biotherapeutics, Inc.1 VarmX B.V.1 Tecsam - Tecnologia e Servicos Medicos1 ADARx Pharmaceuticals, Inc.1 Inari Medical1 CHDI Foundation, Inc.1 Corxel Pharmaceuticals1 European Society of Cardiology1 Frank G. Holz1 Alumis Inc1 Institut de Recherches Internationales Servier1 Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 LifeSprout, Inc.1 Corbus Pharmaceuticals Inc.1 University of Leeds1 Gossamer Bio USA, Inc.1 BioGaia AB1 Akcea Therapeutics1 Miltenyi Biomedicine GmbH1 Medicenna Therapeutics, Inc.1 Cough Monitoring Medical Solutions1 Janssen-Cilag Ltd.1 Puma Biotechnology, Inc.1 Greenwich LifeSciences, Inc.1 ULS Viseu Dão Lafões1 Unidade Local De Saúde Do Norte Alentejano1 University of Ulm1 Fábio Cota Medeiros1 Neurocrine Biosciences1 University of Extremadura1 University Hospital Muenster1 Instituto de Ciências Biomédicas Abel Salazar1 Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.1 eleva GmbH1 Norgine1 European Foundation for Study of Chronic Liver Failure1 Savara Inc.1 Stichting International Registry for Alzheimer's Disease and other Dementias Foundation1 Malo Clinic1 Women's Cancer Study Group GmbH1 Zymeworks BC Inc.1 Marta Sofia Ramos Torres1 Erasmus Medical Center1 Umbria Bioengineering Technologies1 EMD Serono Research & Development Institute, Inc.1 IRCCS Azienda Ospedaliero-Universitaria di Bologna1 European Association of Urology Research Foundation1 Catharina Ziekenhuis Eindhoven1 Medtronic Neurovascular Clinical Affairs1 Immutep S.A.S.1 Alfasigma S.p.A.1 Taiho Oncology, Inc.1 Hospital Universitari Vall d'Hebron Research Institute1 AB Science1 Theravance Biopharma1 Blueprint Medicines Corporation1 Interlinked AB1 Vascutek Ltd.1 Centro Hospitalar Universitário de Santo António1 Institut für Pharmakologie und Präventive Medizin1 Sword Health, SA1 Vividion Therapeutics, Inc.1 Santen SAS1 Calcilytix Therapeutics, Inc., a BridgeBio company1 RHEACELL GmbH & Co. KG1 Zenas BioPharma (USA), LLC1 SECRETO Study Consortium1 4D Molecular Therapeutics1 Liquidia Technologies, Inc.1 Kyowa Kirin Pharmaceutical Development Ltd1 University of Birmingham1 José Manuel Afonso Moreira1 Penumbra Inc.1 Amsterdam UMC, location VUmc1 Montreal Heart Institute1 National and Kapodistrian University of Athens1 Industrial Farmacéutica Cantabria, S.A.1 Medtronic Spinal and Biologics1 PETHEMA Foundation1 Omniartro Lda1 Alimentiv Inc.1 Vifor Pharma, Inc.1 Denali Therapeutics Inc.1 Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III1 Faculty of Sports- Research Center in Physical Activity, Health and Leisure1 AOP Orphan Pharmaceuticals AG1 Centro Medico Teknon1 Kite, A Gilead Company1 Nuvalent Inc.1 Dimerix Bioscience Pty Ltd1 Linkoeping University1 K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc1 AO Innovation Translation Center1 LEO Pharma1 PROCEPT BioRobotics1 Joan Sabater-Riera1 Mirum Pharmaceuticals, Inc.1 University of L'Aquila1 Javier P. Gisbert1 Corcym S.r.l1 Unidade Local de Saude do Nordeste1 Cláudio da Silva Ferreira1 Manuel Coelho da Rocha1 Universitätsklinikum Hamburg-Eppendorf1 Escola Superior Saúde Fernando Pessoa1 DMG Dental Material Gesellschaft mbH1 Protagonist Therapeutics, Inc.1 MedImmune LLC1 Associação Centro de Apoio Tecnológico Agro Alimentar1 Ceric Sàrl1 Clear sponsor filter
Target enrolment
to

Trials in this register

19 of 1109 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Portugal
Start
Recruiting
Amgen
Phase 3
750
Lisbon, Porto, Vila Nova de Gaia
2025-11-28
Active, closed
Amgen
Phase 3
350
Lisbon, Matosinhos Municipality
2025-08-18
Active, closed
Amgen
Phase 3
12,800
Braga, Carnaxide, Coimbra, Guimarães, Lisbon, Matosinhos Municipality, Ponte de Lima, Riachos, Torres Novas
2025-07-25
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
NCT06570798Systemic Lupus Erythematosus, Active Refractory Rheumatoid Arthritis
Amgen
Phase 2
220
Carnaxide, Vila Franca de Xira, Vila Nova de Gaia
2025-07-16
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
Amgen
Phase 3
5,056
Almada, Coimbra, Guimarães, Lisbon, Matosinhos Municipality, Porto, Vila Nova de Gaia
2025-06-25
Recruiting
Amgen
Phase 3
844
Lisbon, Ponte de Lima, Vila Nova de Gaia
2025-02-25
Active, closed
Amgen
Phase 2
61
Braga, Lisbon, Porto
2024-12-26
Recruiting
Amgen
Phase 3
450
Almada, Coimbra, Lisbon, Matosinhos Municipality, Santa Maria da Feira
2024-07-17
Active, closed
Amgen
Phase 3
563
Lisbon, Matosinhos Municipality, Porto
2024-06-05
Active, closed
Amgen
Phase 3
434
Lisbon, Ponte de Lima, Vila Nova de Gaia
2024-04-08
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
Amgen
Phase 3
404
Braga, Lisbon, Porto
2024-02-20
Active, closed
Amgen
Phase 3
633
Setúbal, Lisbon, Porto
2023-11-02
Active, closed
Amgen
Phase 3
509
Lisbon, Matosinhos Municipality, Porto
2023-05-31
Recruiting
Amgen
Phase 3
60
Lisbon, Ponte de Lima, Porto, Vila Nova de Gaia
2022-03-17
Active, closed
A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)
NCT05060016Relapsed/Refractory Small Cell Lung Cancer
Amgen
Phase 2
222
Lisbon, Porto
2021-12-01
Active, closed
Amgen
Phase 3
303
Coimbra, Lisbon, Porto
2021-11-02
Recruiting
Amgen
Phase 1
505
Lisbon, Porto
2020-03-04
Recruiting
Amgen
Phase 3
24
Porto
2019-12-20
Rows per page Showing 1–19 of 19
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Portuguese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 November 2026. https://priyalifescience.com/clinical-trials-portugal

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Portugal and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,109 studies in total at the last sync on 17 Nov 2026, 03:21 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 19 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Portugal?

9 of the 19 studies on this page are recruiting new participants as of the 17 Nov 2026, 03:21 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 19 studies
PhaseStudiesRecruitingShare
Phase 315778.9%
Phase 23115.8%
Phase 1115.3%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Amgen199

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Obesity (2) Sjögren's Syndrome (SS) (1) Extensive-Stage Small-Cell Lung Cancer (1) Small-Cell Lung Cancer (1) Relapsed/Refractory Small Cell Lung Cancer (1) Limited Stage Small Cell Lung Cancer (1) Small Cell Lung Cancer (1) Prostate Cancer (1) Sjögren's Syndrome (1) Active Juvenile Psoriatic Arthritis (1) Atherosclerotic Cardiovascular Disease (1) Overweight (1) Non-Small Cell Lung Cancer (NSCLC) (1) Secondary Hyperparathyroidism (1) Metastatic Castration-resistant Prostate Cancer (1)
→

Browse trials by site location

Lisbon (17) Porto (13) Matosinhos Municipality (7) Vila Nova de Gaia (6) Ponte de Lima (4) Coimbra (4) Braga (3) Carnaxide (2) Guimarães (2) Almada (2) Setúbal (1) Santa Maria da Feira (1)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.